Griffin Asset Management, Inc.
Source: SEC Form 13F · as of Mar 2026Griffin Asset Management, Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $82.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$82.1M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 76,378 | $18.7M |
| ABBVAbbVie Inc. | 78,725 | $17.1M |
| MRKMerck & Co., Inc. | 109,973 | $13.2M |
| ABTABBOTT LABORATORIES | 65,442 | $6.7M |
| PLSEPulse Biosciences Inc Common Stock (DE) | 225,177 | $4.9M |
| ZTSZoetis Inc. | 32,996 | $3.9M |
| BMYBRISTOL MYERS SQUIBB CO | 61,718 | $3.7M |
| SMMTSummit Therapeutics Inc. | 191,872 | $3.6M |
| PFEPFIZER INC | 123,148 | $3.5M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 6,175 | $2.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 6,703 | $1.8M |
| PMPhilip Morris International Inc | 4,506 | $745K |
| LLYELI LILLY & Co | 771 | $709K |
| NVONovo Nordisk A/S | 8,472 | $311K |
| ABSIAbsci Corporation | 56,760 | $170K |
| REPLReplimune Group, Inc. | 14,400 | $110K |
| BMEABiomea Fusion, Inc. | 58,300 | $89K |
| SANASana Biotechnology, Inc. | 14,620 | $42K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.